Developer docs
API playgroundTry for free, no card

Search company profiles

Fluoptics

Full company profile

uuid000is35

Namestring
Fluoptics
Legal namestring
FLUOPTICS SAS
Websiteurl
fluoptics.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Fluoptics SAS is a French medical device company headquartered in Grenoble, France, founded in 2009 and operating as a wholly-owned subsidiary of Getinge AB (Stockholm). The company designs and manufactures fluorescence-based surgical imaging systems, with a portfolio of two dedicated devices: the FLUOBEAM LX Red, which combines autofluorescence and fluorescence perfusion imaging for thyroid and parathyroid surgery, and the FLUOBEAM LM, which uses Indocyanine Green (ICG) fluorescence to provide real-time tissue perfusion imaging in plastic and reconstructive surgery. Both systems employ Class 1 laser technology with high-sensitivity detectors designed to operate under ambient operating-room lighting, and feature an ergonomic joystick interface enabling surgeon-controlled operation from the sterile field.

The underlying technology is near-infrared (NIR) fluorescence and autofluorescence imaging, positioning Fluoptics within a global NIR imaging market valued at USD 2.19B in 2024 and projected to reach USD 2.96B by 2033. The company serves two primary surgical specialties: thyroid and parathyroid surgeons requiring real-time parathyroid gland identification and perfusion visualization, and plastic and reconstructive surgeons needing intraoperative assessment of tissue perfusion and flap viability. Products have been developed and clinically validated by international clinical teams.

Fluoptics generates revenue through capital equipment sales of its FLUOBEAM product line, with pricing not publicly disclosed and US sale restricted to physicians under federal law. Distribution is conducted globally through Getinge's enterprise sales and distribution network, covering EMEA, the Americas, Asia, and Oceania, which is the primary go-to-market channel. The company is listed among key players in the NIR imaging market alongside larger medtech firms including Stryker, KARL STORZ, Olympus, Medtronic, Hamamatsu Photonics, PerkinElmer, and Carl Zeiss Meditec. Headcount is reported at 11–50 employees, consistent with a focused niche medical device operation operating within a much larger parent organization's commercial infrastructure.

Short descriptiontext

Fluoptics SAS is a Grenoble-based medical device subsidiary of Getinge that designs NIR fluorescence imaging systems (FLUOBEAM LX Red and FLUOBEAM LM) for thyroid/parathyroid and plastic/reconstructive surgery, distributed globally through Getinge's enterprise sales network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGrenoble, France
HQ citystring
Grenoble
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
fluorescence imaging devices, surgical imaging equipment, near-infrared imaging, intraoperative visualization, medical laser imaging
Industry2 codes
PRIMARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Fluorescence Imaging Equipment
Social media profiles1 record
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1FLUOBEAM LX Red
Description

An imaging device exclusively dedicated to thyroid and parathyroid surgery, combining autofluorescence and fluorescence perfusion imaging.

getinge.com
+1 more record
Core offering1 text field

Fluoptics develops and manufactures fluorescence imaging systems that help surgeons visualize parathyroid gland location and tissue perfusion in real time during operations. Its product family comprises the FLUOBEAM LX Red, a dual-mode autofluorescence and fluorescence perfusion device for thyroid and parathyroid surgery, and the FLUOBEAM LM, an ICG fluorescence imaging system for plastic and reconstructive surgery. Devices are sold to healthcare professionals through Getinge's global distribution network.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Fluoptics is a medical imaging company that offers a portfolio of fluorescence imaging devices designed for surgical applications. The product line consists of two dedicated devices: FLUOBEAM LX Red (for thyroid and parathyroid surgery) and FLUOBEAM LM (for plastic and reconstructive surgery). Both products leverage autofluorescence and fluorescence perfusion imaging technologies to provide surgeons with real-time visualization of tissue and anatomical structures during surgery, enabling greater precision, efficiency, and safety.

Product and service2 records
1FLUOBEAM LX Red
CategorySurgical Fluorescence Imaging Device
Description

Dedicated imaging device for thyroid and parathyroid surgery that combines autofluorescence and fluorescence perfusion imaging to provide surgeons with unprecedented understanding of parathyroid gland location and tissue perfusion in real time. Intended for surgical specialists and hospitals performing thyroid and parathyroid procedures.

2FLUOBEAM LM
CategorySurgical Fluorescence Imaging Device
Description

Innovative surgical imaging solution using Indocyanine Green (ICG) with integrated fluorescence imaging to provide surgeons with a real-time image of tissue fluorescence in the operative field for perfusion assessment in plastic and reconstructive surgery. Intended for plastic and reconstructive surgeons and associated hospital surgical departments.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major surgical imaging player through its SPY-PHI fluorescence imaging platform for perfusion assessment across plastic, reconstructive and general surgery — directly competes with Fluoptics' FLUOBEAM LM.

TypeDirect peer
Description

Endoscopy and surgical imaging company with NIR/ICG fluorescence imaging systems (e.g., IMAGE1 S Rubina) used in laparoscopic and open surgical workflows — overlaps with Fluoptics' intraoperative fluorescence use cases.

TypeDirect peer
Description

Endoscopic and surgical visualization company offering NIR fluorescence imaging modes integrated into its VISERA and ENDO-AID platforms for general and specialty surgery — direct competitor in NIR surgical imaging.

4Quest Medical Imaging
TypeDirect peer
Description

Specialized fluorescence imaging manufacturer developing multi-wavelength NIR systems for open and minimally invasive surgery — directly competes with Fluoptics as a focused fluorescence imaging peer.

TypeBroad incumbent
Description

Diversified medical technology leader with surgical products and fluorescence imaging integration in laparoscopic and robotic-assisted platforms — competes broadly with Fluoptics across multiple surgical specialties.

6Carl Zeiss Meditec
TypeBroad incumbent
Description

Ophthalmic and surgical microscopy leader with intraoperative fluorescence visualization in neurosurgical and ophthalmic microscope platforms — adjacent competition for fluorescence-based surgical visualization.

TypeOthers
Description

Photonics components and imaging modules supplier whose detectors and light sources underpin many fluorescence imaging systems — enabling technology provider to the NIR surgical imaging ecosystem that Fluoptics participates in.

TypeBroad incumbent
Description

Robotic surgical system (da Vinci) provider that integrates Firefly NIR fluorescence imaging — broad incumbent in surgical visualization with overlapping intraoperative imaging use cases.

TypeBroad incumbent
Description

Surgical microscopy and imaging brand under Danaher, offering fluorescence modules for neurosurgical, ENT and ophthalmic OR workflows — adjacent surgical fluorescence visualization competitor.

TypeOthers
Description

Life sciences and imaging instrumentation company with NIR detection technologies used in research and certain surgical/preclinical imaging applications — enabling/imaging technology participant in the broader NIR imaging market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fluoptics

Surgical Fluorescence Imaging Equipmentfluoptics.com

Fluoptics SAS is a Grenoble-based medical device subsidiary of Getinge that designs NIR fluorescence imaging systems (FLUOBEAM LX Red and FLUOBEAM LM) for thyroid/parathyroid and plastic/reconstructive surgery, distributed globally through Getinge's enterprise sales network.

What Fluoptics does

Fluoptics SAS is a French medical device company headquartered in Grenoble, France, founded in 2009 and operating as a wholly-owned subsidiary of Getinge AB (Stockholm). The company designs and manufactures fluorescence-based surgical imaging systems, with a portfolio of two dedicated devices: the FLUOBEAM LX Red, which combines autofluorescence and fluorescence perfusion imaging for thyroid and parathyroid surgery, and the FLUOBEAM LM, which uses Indocyanine Green (ICG) fluorescence to provide real-time tissue perfusion imaging in plastic and reconstructive surgery. Both systems employ Class 1 laser technology with high-sensitivity detectors designed to operate under ambient operating-room lighting, and feature an ergonomic joystick interface enabling surgeon-controlled operation from the sterile field.

The underlying technology is near-infrared (NIR) fluorescence and autofluorescence imaging, positioning Fluoptics within a global NIR imaging market valued at USD 2.19B in 2024 and projected to reach USD 2.96B by 2033. The company serves two primary surgical specialties: thyroid and parathyroid surgeons requiring real-time parathyroid gland identification and perfusion visualization, and plastic and reconstructive surgeons needing intraoperative assessment of tissue perfusion and flap viability. Products have been developed and clinically validated by international clinical teams.

Fluoptics generates revenue through capital equipment sales of its FLUOBEAM product line, with pricing not publicly disclosed and US sale restricted to physicians under federal law. Distribution is conducted globally through Getinge's enterprise sales and distribution network, covering EMEA, the Americas, Asia, and Oceania, which is the primary go-to-market channel. The company is listed among key players in the NIR imaging market alongside larger medtech firms including Stryker, KARL STORZ, Olympus, Medtronic, Hamamatsu Photonics, PerkinElmer, and Carl Zeiss Meditec. Headcount is reported at 11–50 employees, consistent with a focused niche medical device operation operating within a much larger parent organization's commercial infrastructure.

Fluoptics firmographics

Firmographics
Name
Fluoptics
Legal name
FLUOPTICS SAS
Website
https://fluoptics.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Fluoptics SAS is a Grenoble-based medical device subsidiary of Getinge that designs NIR fluorescence imaging systems (FLUOBEAM LX Red and FLUOBEAM LM) for thyroid/parathyroid and plastic/reconstructive surgery, distributed globally through Getinge's enterprise sales network.
Ownership category
akta.pro rank

Fluoptics industry classification

Industry
Product category
Surgical Fluorescence Imaging Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Fluorescence imaging devices
  • Surgical imaging equipment
  • Near-infrared imaging
  • Intraoperative visualization
  • Medical laser imaging

Where Fluoptics is headquartered

Location

Headquarters

HQ city
Grenoble
HQ country
France
HQ region
Europe

Markets served

Fluoptics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Fluoptics product offering

Product offering

Core offering

Fluoptics develops and manufactures fluorescence imaging systems that help surgeons visualize parathyroid gland location and tissue perfusion in real time during operations. Its product family comprises the FLUOBEAM LX Red, a dual-mode autofluorescence and fluorescence perfusion device for thyroid and parathyroid surgery, and the FLUOBEAM LM, an ICG fluorescence imaging system for plastic and reconstructive surgery. Devices are sold to healthcare professionals through Getinge's global distribution network.

Product overview

Fluoptics is a medical imaging company that offers a portfolio of fluorescence imaging devices designed for surgical applications. The product line consists of two dedicated devices: FLUOBEAM LX Red (for thyroid and parathyroid surgery) and FLUOBEAM LM (for plastic and reconstructive surgery). Both products leverage autofluorescence and fluorescence perfusion imaging technologies to provide surgeons with real-time visualization of tissue and anatomical structures during surgery, enabling greater precision, efficiency, and safety.

Differentiator

Problem solved

Functional benefit

Brands

  • FLUOBEAM LX Red: An imaging device exclusively dedicated to thyroid and parathyroid surgery, combining autofluorescence and fluorescence perfusion imaging.
  • FLUOBEAM LM

Products and services

  • FLUOBEAM LX Red Dedicated imaging device for thyroid and parathyroid surgery that combines autofluorescence and fluorescence perfusion imaging to provide surgeons with unprecedented understanding of parathyroid gland location and tissue perfusion in real time. Intended for surgical specialists and hospitals performing thyroid and parathyroid procedures.
  • FLUOBEAM LM Innovative surgical imaging solution using Indocyanine Green (ICG) with integrated fluorescence imaging to provide surgeons with a real-time image of tissue fluorescence in the operative field for perfusion assessment in plastic and reconstructive surgery. Intended for plastic and reconstructive surgeons and associated hospital surgical departments.

Companies that use Fluoptics

Customer profile

Segments2 records

Ideal customer profiles2 records

Fluoptics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Fluoptics partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Fluoptics competitors and assessment

Company assessment

Direct peers

  • Stryker: Major surgical imaging player through its SPY-PHI fluorescence imaging platform for perfusion assessment across plastic, reconstructive and general surgery — directly competes with Fluoptics' FLUOBEAM LM.
  • KARL STORZ: Endoscopy and surgical imaging company with NIR/ICG fluorescence imaging systems (e.g., IMAGE1 S Rubina) used in laparoscopic and open surgical workflows — overlaps with Fluoptics' intraoperative fluorescence use cases.
  • Olympus: Endoscopic and surgical visualization company offering NIR fluorescence imaging modes integrated into its VISERA and ENDO-AID platforms for general and specialty surgery — direct competitor in NIR surgical imaging.
  • Quest Medical Imaging: Specialized fluorescence imaging manufacturer developing multi-wavelength NIR systems for open and minimally invasive surgery — directly competes with Fluoptics as a focused fluorescence imaging peer.

Broad incumbents

  • Medtronic: Diversified medical technology leader with surgical products and fluorescence imaging integration in laparoscopic and robotic-assisted platforms — competes broadly with Fluoptics across multiple surgical specialties.
  • Carl Zeiss Meditec: Ophthalmic and surgical microscopy leader with intraoperative fluorescence visualization in neurosurgical and ophthalmic microscope platforms — adjacent competition for fluorescence-based surgical visualization.
  • Intuitive Surgical: Robotic surgical system (da Vinci) provider that integrates Firefly NIR fluorescence imaging — broad incumbent in surgical visualization with overlapping intraoperative imaging use cases.
  • Leica Microsystems (Danaher): Surgical microscopy and imaging brand under Danaher, offering fluorescence modules for neurosurgical, ENT and ophthalmic OR workflows — adjacent surgical fluorescence visualization competitor.

Others

  • Hamamatsu Photonics: Photonics components and imaging modules supplier whose detectors and light sources underpin many fluorescence imaging systems — enabling technology provider to the NIR surgical imaging ecosystem that Fluoptics participates in.
  • PerkinElmer: Life sciences and imaging instrumentation company with NIR detection technologies used in research and certain surgical/preclinical imaging applications — enabling/imaging technology participant in the broader NIR imaging market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Fluoptics social profiles

Digital presence

Fluoptics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fluoptics leadership team

Management profile

Number of profiles

Fluoptics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fluoptics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluoptics

What does Fluoptics do?

Fluoptics develops and manufactures fluorescence imaging systems that help surgeons visualize parathyroid gland location and tissue perfusion in real time during operations. Its product family comprises the FLUOBEAM LX Red, a dual-mode autofluorescence and fluorescence perfusion device for thyroid and parathyroid surgery, and the FLUOBEAM LM, an ICG fluorescence imaging system for plastic and reconstructive surgery. Devices are sold to healthcare professionals through Getinge's global distribution network.

Is Fluoptics a public or private company?

Fluoptics is a private company. It is classified as corporate owned and is currently operating.

When was Fluoptics founded?

Fluoptics was founded in 2009. It employs 11 to 50 people.

Where is Fluoptics based?

Fluoptics is headquartered in Grenoble, France, in the Europe region.

Who are Fluoptics's main competitors?

Direct peers on record are Stryker, KARL STORZ, Olympus and Quest Medical Imaging. Broad incumbents are Medtronic, Carl Zeiss Meditec, Intuitive Surgical and Leica Microsystems (Danaher). Others are Hamamatsu Photonics and PerkinElmer.

Does Fluoptics have an API?

No public API is recorded for Fluoptics.

What industry is Fluoptics in?

Fluoptics's product category is Surgical Fluorescence Imaging Equipment. Its primary akta.pro industry code is HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence), with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Straits ResearchNear Infrared Imaging Market Size, Growth & Industry Report 2033The global near infrared imaging market was valued at USD 2.19 billion in 2024 and is projected to reach USD 2.96 billion by 2033, growing at a CAGR of 3.4% during the forecast period. Key factors driving market growth include increasing surgical procedures due to rising chronic disease prevalence and the advantages of NIR imaging over conventional visualization methods, while a lack of skilled professionals may restrain growth in developing economies. North America held the dominant market share in 2024, with Europe expected to be the fastest-growing region, and key players in the market include Quest Medical Imaging, Stryker, KARL STORZ SE and CO., Olympus Corporation, Hamamatsu Photonics, Medtronic, PerkinElmer, Fluoptics, and Carl Zeiss Meditec AG among others.news.cision.comGetinge completes acquisition of FLUOPTICS SASGetinge completed its acquisition of FLUOPTICS SAS, a French fluorescence imaging company, on July 1, 2022. The deal paid approximately 23mEUR in cash, with potential earn-outs, and expands Getinge's clinical decision support offering. The global market is estimated at over SEK 2.5B with 8% annual growth.GetingeGetinge completes acquisition of FLUOPTICS SASGetinge has completed the acquisition of 100% of the shares in FLUOPTICS SAS, a French company specializing in fluorescence imaging for surgery, effective July 1, 2022. The transaction was finalized with a cash payment of approximately 23 million EUR and may include additional earn-out payments based on future milestones. This move expands Getinge's clinical decision support offerings into a global market estimated at over SEK 2.5 billion.news.cision.comGetinge to acquire FLUOPTICS, a technology leader in the area of Near Infrared ImagingGetinge has agreed to acquire 100% of FLUOPTICS SAS, a French company specializing in fluorescence imaging for surgical assistance. The acquisition, valued at approximately EUR 26 million, aims to enhance Getinge's offerings in clinical decision support and provide advanced visualization solutions for surgeons. The transaction is anticipated to close before the end of the second quarter of 2022, pending foreign direct investment approval and other conditions.PR NewswireFDA permits marketing of two devices that detect parathyroid tissue in real-time during surgeryThe FDA permitted marketing of two medical devices (Fluobeam 800 Clinic Imaging Device and Parathyroid Detection PTeye System) for real-time detection of parathyroid tissue during surgical procedures such as thyroidectomy and parathyroidectomy. The Fluobeam 800, developed by Fluoptics, showed a reduction in postoperative hypocalcemia rates from 21% to 5% compared to surgery without the device, while the PTeye System, developed by AiBiomed, demonstrated 93% accuracy in identifying parathyroid tissue presence and 97% accuracy in identifying absence. Both devices use fluorescence technology to help surgeons locate parathyroid tissue without requiring contrast agents, and were reviewed under the FDA's De Novo premarket review pathway.